ArticleCancer immunology, immunotherapy : CII2016

Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma.

Mark R Albertini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.